StockIQpro
NASDAQ:IRIX

Iridex Corp.

Iridex Corp.'s revenue grew 8.2% in fiscal 2025 to $52.7M while operating margin rose to −4.9%, its highest in 10 years. Free cash flow was −$2.3M, −4.3% of revenue, and the diluted share count rose 3.0%.Summary generated from Iridex Corp.'s SEC filings. Latest annual report filed Apr 2, 2026.

Revenue (FY25)$52.7M
Revenue growth+8.2%
Revenue, 5-yr CAGR+7.7%
Gross margin36.5%
Operating margin−4.9%
Net margin−8.4%
ROICn/a
Return on equity−126.4%
Debt / equityn/a
Free cash flow−$2.3M
FCF margin−4.3%
Share count change+3.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue5457524953
Operating income−8−8−10−8−3
Net income−5−8−10−9−4
Free cash flow8−10−7−7−2

Recent filings

From SEC EDGAR

Peers

Electromedical & electrotherapeutic apparatus